Here’s how Medibank compares to the Index since 9 August…
The post Here’s how the Medibank (ASX:MPL) share price has performed against the ASX200 in the last 3 months appeared first on The Motley Fool Australia. –
The Medibank share price certainly didn’t have a pleasant start to the week today. It’s closed at $3.43 a share, down 1.3% for the day.
But how has it fared over the past 3 months? Well, back on 9 August, Medibank shares closed at a price of $3.41 each. That means Medibank shares have gone almost nowhere over the past 3 months (well, a gain of 0.59%) going off those bookend dates.
But that’s not to say the share price did nothing that whole time. In fact, on 7 September, the company hit a new 52-week high of $3.62 a share. By the back end of October, this private health insurance giant descended as low as $3.32 a share. That’s a difference of around 8.3%.
You can see this visually represented in the graph below:
Medibank Private 3-month share price graph & data | Source: fool.com.au
But, as it turns out, this particular 3 month period has resulted in the Medibank share price going nowhere. That’s just how these things work sometimes. So how did the ASX 200 perform by comparison?
Well, the ASX 200 closed at 7,538.4 points back on 9 August. Today, it finished up at 7,452.2 points, a drop of 1.14% over the same period. Suddenly, Medibank’s anaemic performance over this period doesn’t look quite so bad, seeing it was still a market-beating investment.
Saying that, there was another silver lining for Medibank shareholders during this period. On 30 September, Medibank paid out its final dividend for FY21, a 6.9 cents per share payment, fully franked. This dividend in itself is worth a yield of roughly 2% on today’s pricing, so shareholders had that to bank over the past 3 months as well.
Medibank Private share price snapshot
Whilst Medibank has had a rather uninspiring 3 months, its longer-term performance is far more robust. Year to date, Medibank shares are up a healthy 13.95%, outperforming the ASX 200’s 11.49% performance over the same period. Over the past 12 months, Medibank shares are also up by 26.1%, again beating the ASX 200’s 20%.
Should you invest $1,000 in Medibank Private right now?
Before you consider Medibank Private, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.